中低收入环境下丙型肝炎的微量消除：挑战与机遇之窗
Micro-elimination of Hepatitis C in Low- and Middle-Income Settings: Challenges and Windows of Opportunity.
作者信息
Wolpert Barraza Enrique, Kershenobich Stalnikowitz David, Guerrero Guerrero Jorge Enrique, de la Torre Rosas Alethse
机构信息
Dirección Médica ABC Medical Center ABC Hospital México City México.
Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán México City México.
出版信息
Clin Liver Dis (Hoboken). 2021 Aug 10;19(2):38-40. doi: 10.1002/cld.1152. eCollection 2022 Feb.
Abstract
Content available: Author Interview and Audio Recording.
摘要
可获取的内容
作者访谈及音频记录。
相似文献
1
Micro-elimination of Hepatitis C in Low- and Middle-Income Settings: Challenges and Windows of Opportunity.中低收入环境下丙型肝炎的微量消除：挑战与机遇之窗
Clin Liver Dis (Hoboken). 2021 Aug 10;19(2):38-40. doi: 10.1002/cld.1152. eCollection 2022 Feb.
2
Loss to follow-up in the hepatitis C care cascade: A substantial problem but opportunity for micro-elimination.慢性丙型肝炎诊疗环节的失访问题：一个重大问题，但也是实现微消除的机会。
J Viral Hepat. 2020 Dec;27(12):1270-1283. doi: 10.1111/jvh.13399. Epub 2020 Sep 22.
3
Natural history and management of refractory autoimmune hepatitis.难治性自身免疫性肝炎的自然病史与管理
Clin Liver Dis (Hoboken). 2022 Jul 22;20(4):120-123. doi: 10.1002/cld.1231. eCollection 2022 Oct.
4
Viral Kinetics of an Acute Hepatitis B Virus Subgenotype F1b Infection in a Mexican Subject.一名墨西哥受试者急性乙型肝炎病毒F1b亚基因型感染的病毒动力学
Clin Liver Dis (Hoboken). 2022 Mar 10;19(2):41-48. doi: 10.1002/cld.1178. eCollection 2022 Feb.
5
Prospective clinical trials and novel therapies in the medical management of severe alcohol-associated hepatitis.重度酒精性肝炎医学管理中的前瞻性临床试验与新疗法
Clin Liver Dis (Hoboken). 2022 Dec 12;20(6):202-208. doi: 10.1002/cld.1265. eCollection 2022 Dec.
6
Survey of programmatic experiences and challenges in delivery of hepatitis B and C testing in low- and middle-income countries.低收入和中等收入国家乙肝和丙肝检测项目实施经验与挑战调查
BMC Infect Dis. 2017 Nov 1;17(Suppl 1):696. doi: 10.1186/s12879-017-2767-0.
7
[Progress, challenges and countermeasures of global hepatitis C elimination].[全球消除丙型肝炎的进展、挑战与对策]
Zhonghua Gan Zang Bing Za Zhi. 2020 Oct 20;28(10):812-816. doi: 10.3760/cma.j.cn501113-20200929-00539.
8
Diagnosis and management of chronic hepatitis B: A patient-friendly summary of the 2018 American Association for the Study of Liver Diseases practice guidance.慢性乙型肝炎的诊断与管理：2018年美国肝病研究协会实践指南的患者友好型总结
Clin Liver Dis (Hoboken). 2022 Nov 25;20(5):141-145. doi: 10.1002/cld.1240. eCollection 2022 Nov.
9
Additional resource needs for viral hepatitis elimination through universal health coverage: projections in 67 low-income and middle-income countries, 2016-30.通过全民健康覆盖消除病毒性肝炎的额外资源需求：2016-2030 年 67 个低收入和中等收入国家的预测。
Lancet Glob Health. 2019 Sep;7(9):e1180-e1188. doi: 10.1016/S2214-109X(19)30272-4. Epub 2019 Jul 25.
10
Securing sustainable funding for viral hepatitis elimination plans.为消除病毒性肝炎计划确保可持续资金。
Liver Int. 2020 Feb;40(2):260-270. doi: 10.1111/liv.14282. Epub 2019 Dec 5.
引用本文的文献
1
Hepatitis B Virus Genotype H: Epidemiological, Molecular, and Clinical Characteristics in Mexico.乙型肝炎病毒基因型 H：在墨西哥的流行病学、分子和临床特征。
Viruses. 2023 Oct 30;15(11):2186. doi: 10.3390/v15112186.
本文引用的文献
1
Hepatitis C antibody prevalence among Mexico City prisoners injecting legal and illegal substances.墨西哥城囚犯中注射合法和非法物质的丙型肝炎抗体流行率。
Drug Alcohol Depend. 2017 Dec 1;181:140-145. doi: 10.1016/j.drugalcdep.2017.09.026. Epub 2017 Oct 14.
2
Risk factors for prevalent hepatitis C virus-infection among inmates in a state prison system in Mexico.墨西哥某州监狱系统内囚犯中丙型肝炎病毒现患感染的危险因素
PLoS One. 2017 Jun 27;12(6):e0179931. doi: 10.1371/journal.pone.0179931. eCollection 2017.
3
Chronic Hepatitis C Treatment with Direct-Acting Antiviral Agents in a Real-Life Setting.真实环境中使用直接抗病毒药物治疗慢性丙型肝炎
Rev Invest Clin. 2016 Jul-Aug;68(4):203-12.
4
Hepatitis C screening in the general population.
Rev Invest Clin. 2015 Mar-Apr;67(2):104-8.
5
High-risk sexual and drug using behaviors among male injection drug users who have sex with men in 2 Mexico-US border cities.墨西哥-美国边境两座城市中与男性发生性行为的男性注射吸毒者的高危性行为和吸毒行为。
Sex Transm Dis. 2008 Mar;35(3):243-9. doi: 10.1097/OLQ.0b013e31815abab5.
6
Hepatitis C virus infection among HIV-1 infected individuals from northern Mexico.墨西哥北部 HIV-1 感染者中的丙型肝炎病毒感染。
Hepatol Res. 2007 May;37(5):311-6. doi: 10.1111/j.1872-034X.2007.00035.x.
7
Prevalence of hepatitis C virus infection among hemodialysis patients at a tertiary-care hospital in Mexico City, Mexico.墨西哥城一家三级护理医院血液透析患者中丙型肝炎病毒感染的患病率。
J Clin Microbiol. 2004 Sep;42(9):4321-2. doi: 10.1128/JCM.42.9.4321-4322.2004.
Zotero 插件